Licensing

Stronger Together

We're introducing collaboration opportunities in various fields for the growth and innovation of CRISPR gene editing technology. ToolGen, as the pioneer of CRISPR-Cas9 technology, and owner of foundational CRISPR-Cas9 patents, operates an special team comprising legal experts, patent specialists, and licensing professionals, aimed to strategic partnering and licensing. Our goal is to foster innovation and contribute to global industries through the responsible advancement of CRISPR technology.

Contact Us

Feel free to reach out if you're interested in exploring licensing possibilities or have inquiries about our IP practices. Join us as we shape the future of CRISPR genome editing together.

FAQ

If I use gene editing technology by CRISPR-Cas9, do I infringe on any of ToolGen's patents?

I want to develop therapeutics/drugs, plants/seeds, animals, research tools, cell lines/model animals, etc. using CRISPR-Cas9 and then start a business in the United States. Is it possible to do business without patent infringement issues by simply obtaining a patent license from ToolGen?

There is an interference proceeding in the U.S. for patents on the application of CRISPR-Cas9 to eukaryotic cells, what does interference mean?

How does the interference proceed?

What are the potential outcomes of the ongoing patent interference involving ToolGen, CVC, and the Broad Institute in the United States?

Are companies that licensed ToolGen's patents prohibited from doing business in the U.S. until the interference is complete?

Will the outcome of a patent interference proceeding in the U.S. affect ToolGen patents in other countries?

Do I need a license from ToolGen if I am conducting research using CRISPR-Cas9 technology before commercializing a product?

How much does it cost to license ToolGen patents?

Can I obtain an exclusive license for ToolGen’s patented CRISPR-Cas9 technology?

Will I receive technical support If I become a licensee of ToolGen?

Which country are ToolGen’s patents issued?